Agilent Technologies and BaseSolve Informatics Announce Co-Marketing Agreement to Deliver An Integrated NGS Workflow in the United States
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and BaseSolve, a leading provider of advanced bioinformatic analysis and reporting, today announced a U.S.-focused co-marketing agreement to offer customers a powerful, integrated solution for Next-Generation Sequencing (NGS) workflows. This co-marketing agreement applies exclusively to customers within the United States region. The collaboration will provide laboratories in the U.S. with a streamlined...
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and BaseSolve, a leading provider of advanced bioinformatic analysis and reporting, today announced a U.S.-focused co-marketing agreement to offer customers a powerful, integrated solution for Next-Generation Sequencing (NGS) workflows. This co-marketing agreement applies exclusively to customers within the United States region.
The collaboration will provide laboratories in the U.S. with a streamlined NGS workflow solution beginning with quality control of the sample, followed by library preparation and Target Enrichment and ending with data reporting. The integrated offering combines Agilent’s portfolio of trusted genomics instrumentation and reagents with BaseSolve’s innovative software solutions. This workflow has been optimized for both Element and Illumina sequencers in the U.S.
